Samsung to Invest $90 Billion in South Korea to Expand AI Chip, Display, and Battery Production 
Lockheed Martin Emerges as Frontrunner to Acquire Ultra Maritime in $3.5 Billion Defense Deal 
AI Memory Chip Shortage Likely to Persist Despite Korea Investment Boom, Nomura Says 
BHP Workers Approve New Labour Agreement at WA Iron Ore Operations 
Citi Raises TSMC Price Target as AI Chip Demand Strengthens Growth Outlook 
Apple Expands iPhone Lineup, Boosts Foldable iPhone Production Plans Through 2027 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
Meta Cloud Ambitions Could Challenge AWS, Azure, and Google Cloud, Says Morgan Stanley 
Texas Man Charged After Fatal Tesla Full Self-Driving Crash in Katy 
easyJet Agrees in Principle to £5.23 Billion Castlelake Takeover Offer 
Tesla Q2 Deliveries Lift Chinese Auto Suppliers as EV Demand Improves 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
Norway Offshore Oil Workers Reach Wage Deal, Averting Strike 
Suncorp Cuts 2026 Premium Growth Forecast as Australia, New Zealand Markets Weaken 
DOJ Seeks Dismissal of Fraud Charges Against Gautam Adani in U.S. Court 
South Korean biopharmaceutical firm Celltrion Inc. will acquire the patent, trademark, and sales rights for 18 brands of Japan's Takeda Pharmaceutical in Asia-Pacific for 332.4 billion won.
The company will pursue the deal through its Singapore-based affiliate, hoping the complete the acquisition by year's end.
The nine markets covered by business rights include South Korea, Thailand, Malaysia, and Australia.
The 18 brands amassed a combined sales of $140 million in Asia-Pacific in 2018.
Celltrion plans to sell the brands through its affiliates Celltrion Pharma and Celltrion Healthcare.
The acquisition not only helps to stabilize the local supply of medication for hypertension, diabetes, and hyperlipidemia but also serves as Celltrion's first significant move in accelerating its push into the global market.
Celltrion had a net income of 298 billion won in 2019, a 17.5 percent surge from the year before.
